About BrainSpec
BrainSpec is a company based in Boston (United States) founded in 2015. BrainSpec has raised $5.59 million across 5 funding rounds from investors including Techstars, DCVC and Right Side Capital Management. BrainSpec offers products and services including BrainSpec Platform and BrainSpec Core. BrainSpec operates in a competitive market with competitors including Change Healthcare, AIdoc, Cleerly, eCential Robotics and AI Medical Service, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.59 M (USD)
in 5 rounds
-
Latest Funding Round
$1.73 M (USD), Seed
Sep 25, 2017
-
Investors
Techstars
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BrainSpec
BrainSpec offers a comprehensive portfolio of products and services, including BrainSpec Platform and BrainSpec Core.
Web-based system for MRS data analysis and brain chemistry databases.
Tool for creating reference databases for clinical brain metabolite analysis.
People of BrainSpec
Unlock access to complete
Unlock access to complete
Funding Insights of BrainSpec
BrainSpec has successfully raised a total of $5.59M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $1.73 million completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BrainSpec
BrainSpec has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Techstars, DCVC and Right Side Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Pre-seed stage Micro VC firm investing in the US and Canada
|
Locked | Locked | Locked | |
|
Startups are accelerated globally without sector restrictions through structured programs.
|
Locked | Locked | Locked |
Investor details for BrainSpec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BrainSpec
Investment portfolio details for BrainSpec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BrainSpec
Detailed financials for BrainSpec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brainspec Comparisons
Peer comparison for BrainSpec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BrainSpec
BrainSpec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Change Healthcare, AIdoc, Cleerly, eCential Robotics and AI Medical Service, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based solutions are delivered for healthcare payers, providers, and patients.
|
|
| Locked | Locked | Locked |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| Locked | Locked | Locked |
Atherosclerotic plaque is quantified by AI using coronary CT angiograms.
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
Provider of AI-based solution for diagnosis of cancer related lesions
|
|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
Detailed competitors of BrainSpec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brainspec
Complete news archive for BrainSpec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BrainSpec
BrainSpec was founded in 2015 and raised its 1st funding round 2 years after it was founded.
BrainSpec is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
BrainSpec is a funded company, having raised a total of $5.59M across 5 funding rounds to date.
BrainSpec is a web-based Magnetic Resonance Spectroscopy (MRS) software platform. MRS can be performed on any standard MRI scanner and can be used to observe tissue metabolism and for measuring biochemicals. It can help in Alzheimers Disease, epilepsy, traumatic brain injury, multiple sclerosis, schizophrenia, and metabolic disorders. BrainSpec claims to use algorithms which provide most accurate readings for brain metabolites. It also gives a concentration estimate for all the metabolites and also calculates the associated error. The concentration table is colour coded for ease of readability.
BrainSpec's top competitors include Change Healthcare, AIdoc and eCential Robotics.
BrainSpec offers BrainSpec Platform and BrainSpec Core.
BrainSpec has 3 investors. Key investors include Techstars, DCVC, and Right Side Capital Management.